Reformulary_Logo.png
Reformulary Group’s prescription drug tool receives TELUS Outstanding Product Award
May 16, 2018 13:22 ET | Reformulary Group
TORONTO, May 16, 2018 (GLOBE NEWSWIRE) -- Last night at the 33rd annual Canadian Advanced Technology Alliance Leadership Awards Gala, Reformulary Group received the TELUS Outstanding Product...
Expert group to review evidence for use of medical cannabis for employer plans
May 16, 2018 12:53 ET | Reformulary Group
TORONTO, May 16, 2018 (GLOBE NEWSWIRE) -- Today, Reformulary Group, Canada’s leading, independent drug plan management company, announced its Cannabis Formulary Committee, which will review the best...